These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 159778)
41. Concanavalin A-induced suppressor cell activity for T-cell proliferative responses: autologous and allogeneic suppression in aging humans. Schulof RS; Garofalo JA; Good RA; Gupta S Cell Immunol; 1980 Nov; 56(1):80-8. PubMed ID: 6448701 [No Abstract] [Full Text] [Related]
42. Control of lymphocyte stimulation in vitro: "help' and "suppression' in the light of lymphoid population dynamics. Knight SC J Immunol Methods; 1982; 50(1):R51-63. PubMed ID: 6211493 [No Abstract] [Full Text] [Related]
43. Inhibition of humoral and cell-mediated immune responses in man by distinct suppressor cell systems. Lobo PI; Spencer CE J Clin Invest; 1979 Jun; 63(6):1157-63. PubMed ID: 156197 [TBL] [Abstract][Full Text] [Related]
44. Functional evaluation of mouse bone marrow T lymphocytes. Brochu S; Perreault C Transplantation; 1993 Nov; 56(5):1263-5. PubMed ID: 8249135 [No Abstract] [Full Text] [Related]
45. Suppression of cell proliferation after incubation of allogeneically stimulated mouse lymphocytes with concanavalin A: serological analysis of cell subpopulations involved. Hückel C; Kusnierczyk P; Pajtasz E; Brock J Folia Biol (Praha); 1987; 33(3):191-9. PubMed ID: 2957244 [TBL] [Abstract][Full Text] [Related]
46. Network regulation among T cells; conclusions from limiting dilution experiments. Eichmann K; Fey K; Kuppers R; Melchers I; Simon MM; Weltzien HU Springer Semin Immunopathol; 1983; 6(1):7-32. PubMed ID: 6225199 [No Abstract] [Full Text] [Related]
47. [Effect of gangliosides on the activation of human T-suppressors]. Diatlovitskaia EV; Suskova VS; Emets VI; Bergel'son LD Dokl Akad Nauk SSSR; 1986; 288(6):1497-500. PubMed ID: 2942382 [No Abstract] [Full Text] [Related]
48. Quantitative studies on the precursors of cytotoxic lymphocytes. VI. Second signal requirements of specifically activated precursors isolated 12 h after stimulation. Lalande ME; McCutcheon MJ; Miller RG J Exp Med; 1980 Jan; 151(1):12-9. PubMed ID: 6965304 [TBL] [Abstract][Full Text] [Related]
49. Contrasting effects of prostaglandin E2 and indomethacin in modulating Con A-induced human lymphocyte proliferation and suppressor cell development. Skoldstam L; Zoschke D; Messner R Clin Immunol Immunopathol; 1982 Oct; 25(1):32-42. PubMed ID: 6217939 [No Abstract] [Full Text] [Related]
50. Suppression of mixed lymphocyte reactions by alloantigen-activated spleen-localizing thymocytes. Rich RR; Rich SS Cell Immunol; 1976 Mar; 22(2):358-68. PubMed ID: 132277 [No Abstract] [Full Text] [Related]
51. Heterogeneity of concanavalin A-induced suppressor T cells in man defined with monoclonal antibodies. Damle NK; Gupta S Clin Exp Immunol; 1982 Jun; 48(3):581-8. PubMed ID: 6214339 [TBL] [Abstract][Full Text] [Related]
52. Cytolytic T lymphocyte responses to metabolically inactivated stimulator cells. II. Effect of a soluble "costimulator" factor(s) in primary and secondary mixed leukocyte culture. Kelso A; Boyle W Cell Immunol; 1982 Mar; 67(2):370-83. PubMed ID: 6211247 [No Abstract] [Full Text] [Related]
53. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets. Auer IO; Röder A; Fröhlich J Gastroenterology; 1984 Jun; 86(6):1531-43. PubMed ID: 6232166 [TBL] [Abstract][Full Text] [Related]
54. Clonal growth of T cells in vitro: preliminary attempts to a quantitative approach. Watanabe T; Fathman CG; Coutinho A Immunol Rev; 1977; 35():3-37. PubMed ID: 70399 [No Abstract] [Full Text] [Related]
55. Precultured and fresh human T-cells suppress the mitogen response of autologous lymphocytes. Pócsik E; González-Cabello R; Gergely P Immunol Lett; 1983 Feb; 6(2):97-100. PubMed ID: 6221996 [TBL] [Abstract][Full Text] [Related]
56. Suppression of DNA synthesis by con A-activated human lymphocytes: role of monocytes in con A-induced suppression. Kallenberg CG; de Gast GC; The TH Clin Exp Immunol; 1980 Sep; 41(3):583-90. PubMed ID: 6449339 [TBL] [Abstract][Full Text] [Related]
57. [Disturbance of immunogenesis in patients with systemic lupus erythematosus]. Adamian NV; Solov'ev SK; Gambarov SS; Alekseev LP Ter Arkh; 1989; 61(5):43-5. PubMed ID: 2528836 [TBL] [Abstract][Full Text] [Related]
58. Concanavalin A-inducible suppressor cells in regional lymph nodes of cancer patients. Catalona WJ; Ratliff TL; McCool RE Cancer Res; 1979 Nov; 39(11):4372-7. PubMed ID: 159124 [TBL] [Abstract][Full Text] [Related]
59. Concanavalin A-induced suppressor cell activity in Hodgkin's disease. Schulof RS; Lee BJ; Lacher MJ; Straus DJ; Clarkson BD; Good RA; Gupta S Clin Immunol Immunopathol; 1980 Aug; 16(4):454-62. PubMed ID: 6447556 [No Abstract] [Full Text] [Related]
60. Lymphocyte-mediated cytotoxicity against human allogeneic and autologous lymphoid targets after concanavalin A-activation of cytotoxic effector cells. Hunninghake GW; Fauci AS J Immunol; 1977 Sep; 119(3):1122-8. PubMed ID: 70470 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]